Newsroom

BOCA RATON, Fla.--(BUSINESS WIRE)--SourceNow, a leader in workforce technology and contingent workforce solutions, is proud to announce that SourceNow VMS has been recognized as a Top AI-Driven Global Vendor Management Software for 2026 by HR Tech Outlook magazine. This distinguished honor highlights SourceNow’s commitment to innovation, real-world impact, and transformational value in workforce management technology. (HR Tech Outlook) This recognition reflects SourceNow’s continued evolution o...

SEATTLE--(BUSINESS WIRE)--Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making, today announced a new client relationship with Heuro Health, a fast-growing obesity and metabolic health provider integrating GLP-1 medications with physician-led, dietitian-supported, and neuroplasticity-based coaching. Through this collaboration, Heuro Health will incorporate Milliman CareFlowIQ’s risk stratification and real-time...

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has downgraded the Financial Strength Rating to B- (Fair) from B (Fair) and the Long-Term Issuer Credit Rating to “bb-” (Fair) from “bb” (Fair) of Mountain Life Insurance Company (Mountain Life) (headquartered in Lexington, KY). Concurrently, AM Best has placed these Credit Ratings (ratings) under review with developing implications. The ratings reflect Mountain Life’s balance sheet strength, which AM Best assesses as adequate, as well as its marginal ope...

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies Inc. has announced the appointment of Patrik Eriksson as Patterson Dental’s North American president. Eriksson brings a wealth of experience in the dental and medical technology sectors, with a proven track record of developing customer-centric solutions and building result-oriented cultures, where accountability and high team performance are prioritized. He will report to Robert Rajalingam, chief executive officer of Patterson Companies, an...

PENSACOLA, Fla.--(BUSINESS WIRE)--At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, as more than 2,100 women pursue litigation alleging Pfizer failed to adequately warn patients despite long-standing knowledge of the risk. The hearing took place within days of the The US Food and Drug Administration (FDA) approving a label change to Pfizer’s contr...

AUSTIN, Texas--(BUSINESS WIRE)--SolarWinds, a leading provider of simple, powerful, and secure IT management and observability software, today announced it has been named Sterling’s Software Partner of the Year at the 2025 Sterling Technology Summit. The award underscores the close collaboration, trust, and alignment between SolarWinds and Sterling, built through a shared focus on helping customers operate more efficiently, securely, and confidently in increasingly complex IT environments. “Str...

ニューヨーク--(BUSINESS WIRE)--（ビジネスワイヤ） -- ザ・ロック・イット・カンパニーは、DIETLが複数の美術品物流の専門企業を買収したことを発表しました。これにより、DIETLのインフラが強化され、米国の主要なアート市場において、専門的なサービスへのアクセスが拡大します。 買収対象となった企業には、Delaware Freeport、Delaware National Art Company、Techno Export、およびRegistrar Technologiesが含まれます。これらの事業は、美術品の保管、取扱い、梱包、木箱梱包、設置支援、通関仲介、ならびにテクノロジーを活用した物流サービスの各分野において厚みを加えるものであり、DIETLの既存オペレーションを補完します。 高セキュリティかつ空調管理下の美術品保管サービスを提供するDelaware Freeportは、今後「Delaware Freeport by DIETL」として運営され、コレクターや機関向けに信頼される保管拠点としてDIETLのポートフォリオに加わります。米国拠点の外国貿易地区かつ...

SOUTHPORT, Conn.--(BUSINESS WIRE)--Stormfield Capital®, a private real estate credit investment firm specializing in short-term bridge, transitional, and construction lending announced today that it has surpassed $2 billion in cumulative loan originations since inception. The milestone highlights Stormfield’s rapid growth and sustained demand for flexible, execution-oriented capital across residential and multifamily real estate markets. The firm’s origination volume has accelerated as communit...

加州聖卡洛斯--(BUSINESS WIRE)--(美國商業資訊)-- 全球性腫瘤公司BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235)今日公布第三期HERIZON-GEA-01臨床試驗的完整結果。該試驗旨在評估HER2標靶雙特異性抗體ZIIHERA® (zanidatamab)聯合化療（加用和不加用PD-1抑制劑TEVIMBRA® (tislelizumab)）用於一線治療人類表皮生長因數受體2陽性(HER2+)局部晚期或轉移性胃食管腺癌(GEA)的療效。包含首次中期總存活期(OS)分析在內的上述數據將於2026年1月8日太平洋標準時間上午8:57至9:07，在2026年美國臨床腫瘤學會胃腸道腫瘤研討會(ASCO GI)上以最新突破性摘要口頭報告(#LBA285)的形式對外公布。 HERIZON-GEA-01試驗達到無進展存活期(PFS)這一雙重主要終點，相較於對照組，兩個試驗組均實現了具有統計學顯著性和臨床意義的改善。在ZIIHERA聯合化療的基礎上加入TEVIMBRA後，總存活期(OS)同樣獲得具有統計學顯著性...

SAN CARLOS, Californie--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq : ONC ; HKEX : 06160 ; SSE : 688235), une société mondiale d'oncologie, annonce aujourd'hui les résultats complets de l'essai HERIZON-GEA-01 de phase 3 évaluant le ZIIHERA® (zanidatamab), un anticorps bispécifique ciblé par HER2, en association avec une chimiothérapie, avec et sans l'inhibiteur de PD-1, TEVIMBRA® (tislelizumab), en tant que traitement de première intention de l'adénocarcinome gastro-œsophagien localement avan...